Dynamics of suppression and recovery of plasma FSH, LH, androstenedione and testosterone in polycystic ovarian disease using an oral contraceptive.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000735:Androstenedione / Q000097:blood*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood*; D006801:Humans; D007457:Iodine Radioisotopes; D007986:Luteinizing Hormone / Q000097:blood*; D008656:Mestranol; D009640:Norethindrone; D011085:Polycystic Ovary Syndrome / Q000097:blood* / Q000652:urine; D011863:Radioimmunoassay; D013739:Testosterone / Q000097:blood*; D013997:Time Factors
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D007457:Iodine Radioisotopes; D013739:Testosterone; D000735:Androstenedione; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D008656:Mestranol; D009640:Norethindrone